Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
168.92
+4.68 (2.85%)
Feb 20, 2026, 4:00 PM EST - Market closed
CRL Stock Forecast
Stock Price Forecast
The 11 analysts that cover CRL stock have a consensus rating of "Buy" and an average price target of $199.64, which forecasts a 18.19% increase in the stock price over the next year. The lowest target is $170 and the highest is $265.
Price Target: $199.64 (+18.19%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 3 | 4 | 4 | 4 | 4 |
| Hold | 10 | 9 | 7 | 6 | 6 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 15 | 14 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $251 → $235 | Strong Buy | Maintains | $251 → $235 | +39.12% | Feb 20, 2026 |
| Mizuho | Mizuho | Hold Maintains $215 → $175 | Hold | Maintains | $215 → $175 | +3.60% | Feb 20, 2026 |
| Barclays | Barclays | Buy Maintains $215 → $200 | Buy | Maintains | $215 → $200 | +18.40% | Feb 19, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $200 | Buy | Maintains | $260 → $200 | +18.40% | Feb 19, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $200 → $265 | Strong Buy | Maintains | $200 → $265 | +56.88% | Jan 16, 2026 |
Financial Forecast
Revenue This Year
4.12B
from 4.02B
Increased by 2.51%
Revenue Next Year
4.31B
from 4.12B
Increased by 4.66%
EPS This Year
10.99
from -2.91
EPS Next Year
12.21
from 10.99
Increased by 11.12%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.4B | 4.8B | |||
| Avg | 4.1B | 4.3B | |||
| Low | 4.0B | 4.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.7% | 16.4% | |||
| Avg | 2.5% | 4.7% | |||
| Low | -1.6% | -0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.98 | 14.59 | |||
| Avg | 10.99 | 12.21 | |||
| Low | 9.61 | 10.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 32.8% | |||
| Avg | - | 11.1% | |||
| Low | - | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.